Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: May 13, 2025
Q1 2025 Net Product Sales Increased 77% Year-over-Year to $3.1 Million
Sustained Momentum Driven by Growing Prescriber Adoption and Repeat Patient Use
Read more at globenewswire.comNASDAQ:EVOK (6/11/2025, 8:00:02 PM)
3
+0.15 (+5.26%)
Find more stocks in the Stock Screener
